AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Euglim-M 1mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Bayer Zydus Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Euglim-M 1mg/500mg Tablet PR

Diabex Duo 1mg/500mg tablets are classified as antidiabetic agents, combining two medications for adult type 2 diabetes management. This formulation helps regulate blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Primary Ingredients of Euglim-M 1mg/500mg Tablet PR

The information is unavailable.

Uses of Euglim-M 1mg/500mg Tablet PR

Managing Type 2 diabetes

Major Benefits of Euglim-M 1mg/500mg Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Take Euglim-M 1mg/500mg Tablets PR with meals.

Common Side effects of Euglim-M 1mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Euglim-M 1mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Take Euglim-M 1mg/500mg Tablet PR with food.

How Euglim-M 1mg/500mg Tablet PR works:

Euglim-M 1mg/500mg tablets contain a dual antidiabetic formulation of glimepiride and metformin. Glimepiride, a sulfonylurea derivative, enhances pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Euglim-M 1mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Euglim-M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Euglim-M 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Euglim-M 1mg/500mg Tablet PR, as dosage modification may be necessary. Consult your physician for guidance. Euglim-M 1mg/500mg Tablet PR is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Euglim-M 1mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically recommended for individuals with mild to moderate liver disease; its administration is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Euglim-M 1mg/500mg Tablet PR :

Should you forget to take your Euglim-M 1mg/500mg Tablet PR, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Euglim-M 1mg/500mg Tablet PR

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Euglim-M 1mg/500mg Tablet PR

Store the medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any remaining medication after use. Prevent access to this medicine by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Euglim-M 1mg/500mg Tablet PR. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Euglim-M 1mg/500mg Tablet PR use and seek immediate medical attention.
Euglim-M 1mg/500mg tablets are a dual-drug formulation containing glimepiride and metformin, indicated for managing type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used concurrently with a healthy diet and exercise regimen. Glimepiride functions by stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and enhances insulin responsiveness. This combination therapy is unsuitable for treating type 1 diabetes.
Taking Euglim-M 1mg/500mg tablets may cause common side effects such as low blood sugar, taste changes, nausea, abdominal discomfort, loose stools, and headaches. Rare but potentially serious adverse reactions include lactic acidosis. Prolonged treatment might result in a Vitamin B12 deficiency.
Indeed, prolonged administration of Euglim-M 1mg/500mg tablets may induce Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency can lead to anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait disturbances. Prophylactic annual supplementation with exogenous Vitamin B12 has been proposed by some investigators to mitigate these risks.
Indeed, Euglim-M 1mg/500mg tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other anti-diabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Euglim-M 1mg/500mg tablets with alcohol is unsafe due to the risk of significantly reduced blood sugar (hypoglycemia) and a heightened probability of lactic acidosis.
Euglim-M 1mg/500mg Tablet...
94
MRP 115
18% off